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Abstract 
Tobacco smoking in the form of cigarette is a common habit prevalent among undergraduates in higher 
institutions. Chronic tobacco smoking remains the primary risk factor for chronic obstructive pulmonary disease 
(COPD). Pulmonary function test provide an objective quantifiable measure of lung function. This study was 
undertaken to assess lung function using PEFR among smokers and non smokers. In this study 100 male students 
within the age range of 18- 35 years were recruited, 50 were smokers forming the case group and 50 were non 
smokers forming the control group. The result showed no significant difference in mean physical parameters 
between smokers and non smokers. The smokers were mainly mild smokers.  There was a significant decrease at 
P< 0.05 in PEFR of smokers when compared to non smokers. The actual value of PEFR decreased with 
increased quantity of smoking but this decrease was not statistically significant, indicating that airway 
obstruction may occur irrespective of the quantity or duration of cigarette smoking. 
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INTRODUCTION  
Smoking is a known risk factor for cardiovascular disease, chronic obstructive pulmonary disease (COPD), 
cardiovascular disease and certain cancers, especially the lung cancer. The morbidity and mortality with tobacco 
use is entirely preventable. 
Cigarette is produced from tobacco. Tobacco plant is believed to have originated in the western 
hemisphere. The plant is grown for its leaves which can be smoked, chewed or sniffed for a variety of effects. It 
is considered as an active substance especially because of its nicotine content. 
It is interesting to note that though the prevalence of cigarette smoking in rural areas is lower than in 
urban areas, the number of cigarette smoker in rural areas is higher than in urban areas. A quarter of smokers 
develop chronic obstructive pulmonary diseases and is the fourth commonest cause of death worldwide. OPD is 
characterized by airflow limitation that is not fully reversible. Air flow limitation may be due to inflammation or 
due to increase in the thickness of the wall. PEFR is a useful parameter to monitor airway obstruction, assess its 
severity and variation and evaluate the effects of treatment. Earlier studies have reported that the PEFR is an 
effort dependent parameter emerging from large airways and it does not detect small airway obstruction. Several 
studies have reported that PEFR was significantly lower in smokers than in non-smokers.It is estimated that a 
third of world’s population, aged 15 years and above are smokers (Corrao et al, 2000. In the twentieth century, 
the tobacco epidemic was estimated to have killed 100million people worldwide, but unless urgent action is 
taken, the number of deaths could increase to one billion in this century (2008). 
In Nigeria, the prevalence of adults smoking in 2002 was 8.6% (Shatey et al).The primary objective of 
the present study was to measure and compare the peak expiratory flow rate (PEFR) among smokers and non-
smokers in University of Jos, to study the role of possible associated factors and relation of quantity and duration 
of smoking on the peak expiratory flow rate in University of Jos students. 
 
MATERIALS AND METHODS  
The study was carried out in Jos, Plateau state, Nigeria, using students of the University of Jos. The study 
population included 100 male subjects. They were divided into two groups. The test group included 50 subjects 
who were smokers, and controls included 50 healthy non-smokers (in the age group of 18-35 years). Groups 
were matched for age, height, weightand chest circumference. Prior to any measurement, questionnaires eliciting 
information on age, medical history and smoking habit was administered to all the selected subjects. 
Inclusion Criteria: 
Individuals aged between 18-35 years with history of smoking cigarettes daily for atleast one year were 
considered as smokers (Gupta et al, 1995). All the subjects were registered male students of various Departments 
in University of Jos, Nigeria. 
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Exclusion Criteria: 
Inability or unwillingness to take part in the study; history of major cardiopulmonary diseases like acute 
myocardial infarction, pulmonary tuberculosis e.t.c. Also ex-smokers or past smokers were excluded from the 
study. 
 The subjects were subjected to anthropometry at the point of entry using the standard procedures and 
instruments. Age was recorded from birthday by calendar to the nearest of year (<6 months and >6 months). 
Standing height was recorded without shoes and with light clothes on a wall mounted measuring tape to the 
nearest of centimeter (<5mm and >5mm). Weight was recorded without shoes and with light clothes in 
kilograms to the nearest 0.5kg using a potable bathroom weighing scale. (Hana B.R., 9012). 
 Chest circumference was recorded using a measuring tape to within 0.1cm. 
 A peak flow meter (Vitalograph,Ennis,Ireland) was used. Briefly, the mouth of this apparatus was 
constantly disinfected with methylated spirit before each use by the subject. The subjects took maximal 
inspiration and then give out a maximal expiration and the PEFR was read directly from the meter scale. A reset 
was made to return the pointer to zero and maneuver was repeated. The best of the three broadly reproducible 
attempts was taken as the PEFR. 
 The quantification of tobacco smoking was done by calculating the smoking index. 
Smoking Index: It is equal to multiplication of the average number of cigarettes smoked per day and duration (in 
years) of tobacco smoking (Gupta et al, 1995; Sanjay et al, 2006). 
Habit    Smoking Index  
    (Frequency X duration) 
Non-smokers   0 
Light/mild smokers  1-100 
Moderate smokers   101-200 
Heavy Smokers   More than 200   
Statistical Analysis  
Graph pad prism version 5.02 was used to analyze data obtained and these were expressed as mean ± standard 
deviation. 
 The differences between means were compared using unpaired t-test. “P” Value <0.05 is taken as 
significant. Analysis was also done by one way ANOVA. 
 
RESULTS 
Physical Characteristics of Smokers and Non-Smokers  
 There was no significant difference in mean physical parameters like age, height, weight and chest 
circumference by calculating mean and standard deviation in smokers and non-smokers (Table 1). 
Table 1: Physical Characteristics of Smokers and Non-smokers 
Characteristics Smokers  Non-smokers P-value  
Age (Years) 26.46±2.581 26.16±3.096 0.4946 
Height (m) 1.669±0.0924 1.686±0.05866 0.2668 
Weight (kg) 66.42±7.530 67.10±8.765 0.6782 
Chest circumference (cm) 88.32±8.726 88.56±6.837 0.8786 
 Data presented as mean± SD 
Peak Expiratory Flow Rate (PEFR) among smokers and non-smokers 
Table 2, showed a statistically highly significant association in peak expiratory flow rate (PEFR) between 
smokers and non-smokers by applying unpaired t-test of significance (p<0.0001) 
Table 2: Peak Expiratory Flow Rate (PEFR) among smokers and non-smokers 
 
PEFR (L/min) 
Smokers Non-smokers  
430.0±67.10*** 527.6±99.95 
P<0.0001 
Frequency and Percentage of subject According to Smoking Index  
Most smokers were light or mild smokers (66%) followed by moderate (28%) and heavy smokers (6%) (Table 3) 
Table 3: Frequency and Percentage of subject according to Smoking Index 
Smoking Index Frequency Percentage 
1 – 100 33 66% 
101 – 200 14 28% 
>200 3 6% 
Total 50 100% 
Association of Grade of Smoking with Peak expiratory Flow rate (PEFR). 
Table 4 showed no statistical significant difference in peak expiratory flow rate among the different grade of 
smokers when compared with non-smokers 
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Table 4: Association of Grade of Smoking with PEFR 
Grade of Smoking PEFR Parameters  
Mild 443.30± 69.76 
Moderate 40.12± 12.00 
Heavy 363.30± 51.32 
Non smoker 430.0+67.10 
Data presented as mean± SD. Analysis of data was done by one way ANOVA p<0.05 
 
Discussion 
Tobacco has remained as one of the most important predisposing factors responsible for so many respiratory and 
cardiovascular diseases. Chronic Obstructive Pulmonary Disease (COPD) has been recognized as one of the 
most important causes of morbidity and mortality in chronic tobacco smokers all over the World (Prasad et al, 
2003). 
 Smoking is responsible for more than 90% of the chronic obstructive airway disease within one to two 
years of smoking regularly and many young smokers will develop inflammatory changes in their small airways. 
After twenty years path, physiological changes in lung develop and progress in proportion to intensity and 
duration of smoking (Madison et al, 1998). 
 During the last few decades, lung function tests evolved from tools for physiologic study of clinical 
investigations in assessing respiratory status. They also became a part of routine health examination in 
respiratory, occupational, sport medicine and in public health screening. Tests have been designed to indicate the 
extent of the narrowing of the airway. 
 Narrowing of the airways reduces the ability to move air in and out of the lungs. The narrower the tubes, the 
lower will be the PEFR (Diner et al, 2000). 
In the present cross sectional comparative study, 100 subjects were randomly selected to study the 
effect of smoking habits on pulmonary function by using PEFR measurement. It was observed that there was no 
significant difference in the mean physical parameters like age, height, weight and chest circumference thereby 
showing proper matching of smokers and non-smokers (table 1). Most of the smokers were mild smokers (66%) 
(Table 3). This could be attributed to the fact that they study population were young adult and have been 
smoking cigarette for a short duration. Pulmonary function parameter (PEFR) showed no statistical significant 
association among the different grade of smokers when compared with Non smokers by one way ANOVA 
(Table 4). Also, the result showed that the peak expiratory flow rate was statistically highly significantly less 
(p<0.0001) in the cigarette smokers than in the non-smokers by applying unpaired t-test (table 2). This finding is 
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consistent with the report of (Tanko et al, 2012; Ebomoyi et al, 2005; Hussainet al, 2007 and Wafaaet al, 2010) 
who observed a reduced PEFR in smokers than non-smokers. 
Cigarette smoke increase airway resistance and decrease PEFR several mechanisms. It can be attributed 
to rapidly responding receptors within the airway causing bronchoconstriction. A possible reason for the 
decrease in PEFR could be inflammation which is a common and constant pathological finding in cigarette 
smokers. There is usually increase in airflow limitation as a result of bronchial constriction used by mediators of 
inflammation. This inflammation either directly increases smooth muscle tone or indirectly cause airway fibrosis. 
All these processes cause wall thickness leading to airway narrowing and flow limitation. 
The accumulated effect of tobacco smoke is an increased load on oxidants in the respiratory tract, both 
directly by inhalation of oxidants in the smoke and indirectly by activation of inflammatory cells (Kucokset al, 
1999). Smoking significantly increases progressive deterioration of the lung functions and is a risk factor in 
chronic obstructive pulmonary diseases. In which pulmonary mechanics deteriorates and causes loss of elastic 
recoil of the lungs and slowing forced expiration (Gold et al., 1996). With nicotine, mucus producing cells grow 
in size and number, so that the amount of mucus secreted is more and also thicker (Gold et al., 1996). Cigarette 
smoke slows the movement of cillia on the airway epithelium and also reduces their number, making 
mucocilliary clearance difficult and further clogging up the airway (West et al, 1995). 
Furthermore, nicotine promotes tumor growth and angiogenesis in adults. It can induce angiogenesis by 
activating nicotinic acetylcholine receptors (nAchRs) on the surface endothelial cells which stimulates their 
proliferation and the subsequent formation of blood vessels (Zhu et al., 2003). Cigarette smoke also increases 
levels of chemo attractant protein and vascular endothelial growth factor which also aid angiogenesis and tumor 
growth (Flintoft L., 2003). It is also known that cigarette smoke can induce remodeling in the trachea in the 
absence of inflammation (Andrew et al,2008). 
 
Conclusion 
It can be concluded that the smokers among the undergraduates of university of Jos are mostly mild 
smokers.Also the value of PEFR is lower in active tobacco smokers than non-tobacco smokers.The actual value 
of PEFR decreases as the number of tobacco smoking product increases and peak flow lower in moderate 
smokers than in mild smokers and lower in heavy smokers than in mild and moderate smokers.These differences 
in PEFR among the grade of smokers is not significant indicating that airways obstruction occurs irrespective of 
the duration of smoking. 
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